We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$9.33M
Cap. Flow %
-0.27%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135

Top Buys

Rank Stock Value
1
JNPR
Juniper Networks
JNPR
+$162M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS
Ansys
ANSS
+$119M
4
X
US Steel
X
+$104M
5
CTLT
CATALENT, INC.
CTLT
+$93.3M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$561M
2
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$120M
3
IMGN
Immunogen Inc
IMGN
+$56.8M
4
CPRI icon
Capri Holdings
CPRI
+$44.2M
5
PXD
Pioneer Natural Resource Co.
PXD
+$34M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Materials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WEL
226
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.42M 0.04%
125,054
– –
INZY
227
DELISTED
Inozyme Pharma
INZY
$1.4M 0.04%
183,218
-61,710
-25% -$339K
GLPI icon
228
Gaming and Leisure Properties
GLPI
$12.8B
$1.37M 0.04%
29,775
+5,642
+23% +$260K
EWTX icon
229
Edgewise Therapeutics
EWTX
$4.78B
$1.37M 0.04%
75,097
-39,588
-35% -$629K
PDM
230
Piedmont Realty Trust
PDM
$1.18B
$1.33M 0.04%
+189,600
New +$1.27M
NFYS
231
DELISTED
Enphys Acquisition Corp.
NFYS
$1.33M 0.04%
122,826
– –
BDTX icon
232
Black Diamond Therapeutics
BDTX
$110M
$1.3M 0.04%
+257,000
New +$1.04M
ARVN icon
233
Arvinas
ARVN
$568M
$1.3M 0.04%
31,501
-59,631
-65% -$2.61M
PEN icon
234
Penumbra
PEN
$12.8B
$1.29M 0.04%
5,798
+150
+3% +$37.1K
ORIC icon
235
Oric Pharmaceuticals
ORIC
$1.34B
$1.27M 0.04%
92,366
-170,590
-65% -$2.03M
MTCH icon
236
Match Group
MTCH
$8.4B
$1.27M 0.04%
35,000
-5,000
-13% -$181K
CVLT icon
237
Commault Systems
CVLT
$5.53B
$1.27M 0.04%
+12,500
New +$1.13M
DOC icon
238
Healthpeak Properties
DOC
$14.5B
$1.26M 0.04%
67,200
-98,330
-59% -$1.79M
RVNC
239
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.25M 0.04%
254,667
+145,000
+132% +$858K
MFA
240
MFA Financial
MFA
$915M
$1.25M 0.04%
+109,800
New +$1.23M
MIRM icon
241
Mirum Pharmaceuticals
MIRM
$5.74B
$1.25M 0.04%
49,857
-55
-0.1% -$1.51K
NVNO
242
enVVeno Medical
NVNO
$6.78M
$1.23M 0.04%
6,466
-286
-4% -$51.3K
OFIX icon
243
Orthofix Medical
OFIX
$432M
$1.22M 0.04%
84,249
+4,000
+5% +$55.3K
RCUS icon
244
Arcus Biosciences
RCUS
$3.61B
$1.21M 0.03%
64,122
+10,876
+20% +$188K
VERA icon
245
Vera Therapeutics
VERA
$2.3B
$1.19M 0.03%
27,566
-79,406
-74% -$2.83M
PYPL icon
246
PayPal
PYPL
$51.1B
$1.17M 0.03%
17,500
-32,500
-65% -$1.99M
LBPH
247
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$1.17M 0.03%
54,053
-69,153
-56% -$1.51M
PATH icon
248
UiPath
PATH
$7.25B
$1.13M 0.03%
50,000
-100,000
-67% -$2.34M
KROS icon
249
Keros Therapeutics
KROS
$211M
$1.13M 0.03%
17,053
+2,941
+21% +$174K
ASML icon
250
ASML
ASML
$655B
$1.12M 0.03%
+1,156
New +$1.03M
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.